Dorling Janet - Insider Non-Derivative Transactions at CymaBay Therapeutics, Inc. (CBAY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 12, 2024, Dorling Janet's relationship to CymaBay Therapeutics, Inc. (CBAY) is Director, and currently has 6,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CBAY insiders.
Data Source: SEC.
Dorling Janet - Insider Non-Derivative Transactions of CBAY Common Stock
Dorling Janet - Insider Non-Derivative Transactions at CBAY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 13, 2024 | Sell -- (Common Stock) | 6000 | 31.97 | 0 |
| Feb 13, 2024 | M -- (Common Stock) | 6000 | 4.63 | 6000 |
| Jan 11, 2024 | Sell -- (Common Stock) | 6000 | 23.86 | 0 |
| Jan 11, 2024 | M -- (Common Stock) | 6000 | 4.63 | 6000 |
| Dec 12, 2023 | Sell -- (Common Stock) | 6000 | 20.07 | 0 |
| Dec 12, 2023 | M -- (Common Stock) | 6000 | 4.63 | 6000 |
| Nov 11, 2023 | Sell -- (Common Stock) | 7000 | 15.24 | 0 |
| Nov 11, 2023 | M -- (Common Stock) | 7000 | 4.63 | 7000 |